Testing effectiveness (Phase 2)Study completedNCT00685399What this trial is testingSafety and Efficacy of AIN457 in Noninfectious UveitisWho this might be right forNon-infectious Uveitis Novartis Pharmaceuticals 76
Early research (Phase 1)UnknownNCT04120636What this trial is testingPhase I Study of Episcleral Celecoxib for Treatment of Macular Edema and Inflammatory Disorders of the Posterior PoleWho this might be right forMacula EdemaRadiation RetinopathyBranch Retinal Vein Occlusion+4 more Targeted Therapy Technologies, LLC 3
Testing effectiveness (Phase 2)Ended earlyNCT02125266What this trial is testingSafety and Preliminary Efficacy Study of V404 PDS in UveitisWho this might be right forUveitis, PosteriorUveitis, Intermediate Forsight Vision4 7
Post-approval studies (Phase 4)Study completedNCT03816397What this trial is testingAdalimumab in JIA-associated Uveitis Stopping TrialWho this might be right forUveitisJIA Nisha Acharya 87
Large-scale testing (Phase 3)Study completedNCT00404742What this trial is testingLX211 in Clinically Quiescent Non-infectious Intermediate, Anterior and Intermediate, Posterior or Pan-UveitisWho this might be right forUveitis, PosteriorUveitis, IntermediatePanuveitis Lux Biosciences, Inc. 232
Not applicableStudy completedNCT03155243What this trial is testingImpact of Humira® Therapy on Ocular Inflammation, Selected Health Care Resource Utilization and Patient Reported Outcomes in Patients With Active Non-infectious Intermediate, Posterior and Panuveitis in Routine Clinical PracticeWho this might be right forUveitis AbbVie 155
Not applicableStudy completedNCT00570830What this trial is testingRetisert and Cataract Surgery in Patients With Severe UveitisWho this might be right forIntermediate UveitisPosterior Uveitis Duke University 21
Post-approval studies (Phase 4)Ended earlyNCT03656692What this trial is testingSafety and Effectiveness of Acthar Gel for Inflammation of the Eye's Uvea (Middle Layer)Who this might be right forUveitis, PosteriorUveitis, IntermediatePanuveitis Mallinckrodt 5
Large-scale testing (Phase 3)Study completedNCT00404612What this trial is testingLX211 in Active Sight Threatening, Non-infectious Intermediate-, Anterior and Intermediate-, Posterior-, or Pan-UveitisWho this might be right forUveitis, PosteriorUveitis, IntermediatePanuveitis Lux Biosciences, Inc. 218
Post-approval studies (Phase 4)Study completedNCT05414201What this trial is testingAssess Change in Disease Activity and Adverse Events of Adalimumab in Chinese Participants Requiring High Dose Corticosteroids for Active Non-Infectious Intermediate, Posterior, or Pan-UveitisWho this might be right forNon-infectious Intermediate Posterior- or Pan-uveitis AbbVie 87
Large-scale testing (Phase 3)Ended earlyNCT02375685What this trial is testingLong-term Safety of Gevokizumab in the Treatment of Patients With Chronic Non-infectious Uveitis (EYEGUARD-X)Who this might be right forChronic Uveitis Institut de Recherches Internationales Servier 71
Testing effectiveness (Phase 2)Ended earlyNCT01314417What this trial is testingTreatment of Non-infectious Intermediate and Posterior Uveitis Associated Macular Edema With Intravitreal MethotrexateWho this might be right forNon-infectious Intermediate and Posterior Uveitis National Eye Institute (NEI) 2
Not applicableStudy completedNCT00001738What this trial is testingVascular Endothelial Growth Factor (VEGF) in UveitisWho this might be right forMacular Edema, CystoidUveitis National Eye Institute (NEI) 60
Early research (Phase 1)Study completedNCT00280826What this trial is testingEfalizumab to Treat UveitisWho this might be right forUveitisMacular Edema National Eye Institute (NEI) 6
Large-scale testing (Phase 3)Study completedNCT02595398What this trial is testingSuprachoroidal Injection of CLS-TA in Subjects With Macular Edema Associated With Non-infectious UveitisWho this might be right forUveitisUveitis, PosteriorUveitis, Anterior+2 more Clearside Biomedical, Inc. 160
Not applicableStudy completedNCT00331331What this trial is testingThe Vitreous Proteome and Inflammatory Mediators in Ocular Inflammatory DiseaseWho this might be right forUveitisVasculitisOcular Inflammatory Disease National Eye Institute (NEI) 147
Testing effectiveness (Phase 2)Study completedNCT01900431What this trial is testingPhase II Study to Analyze Sarilumab in Non-Infectious UveitisWho this might be right forUveitis Sanofi 58
Testing effectiveness (Phase 2)Study completedNCT03308045What this trial is testingEvaluation of EYS606 in Patients With Non-infectious Posterior, Intermediate or PanuveitisWho this might be right forNon-infectious Uveitis Eyevensys 15
Not applicableEnded earlyNCT00539370What this trial is testingHuman Samples and Data RepositoryWho this might be right forUveitisScleritis National Eye Institute (NEI) 1,862
Testing effectiveness (Phase 2)Study completedNCT00326508What this trial is testingCombination Daclizumab/Denileukin Diftitox to Treat UveitisWho this might be right forNon-infectious Intermediate and Posterior Uveitis National Eye Institute (NEI) 5